Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Medullary × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Lymphoma, B-Cell, Marginal Zone 4 Barrett Esophagus 4 Lymphoma, Large B-Cell, Diffuse 3 Breast Neoplasms 3 Zollinger-Ellison Syndrome 2 Squamous Cell Carcinoma of Head and Neck 2 Lymphoma 2 Inflammation 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Ulcer 1 Solid Tumours 1 Solid Tumor 1 Precancerous Gastric Lesions 1 Pharmacokinetics of MDV3100 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hyperuricemia 1 Healthy Adult Participants 1 Gout 1 Gastrinoma 1 Esophagitis, Peptic 1

Interventions

vandetanib 9 Everolimus 4 sargramostim 2 cabozantinib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Gefitinib 2 yeast-CEA vaccine 1 vatalanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sacubitril and valsartan sodium hydrate drug combination 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 pasireotide 1 nintedanib 1 motesanib diphosphate 1 mercaptoundecahydrododecaborate 1 lenvatinib 1 fluorodopa F 18 1 cixutumumab 1 anlotinib 1 aldesleukin 1 Vorinostat 1 Vinorelbine 1 Thalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01539655 2017-05-02

Vandetanib

Sanofi

Phase 1 Completed

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡